In one male participant we identified a pathogenic CHEK2 variant, which leads to a dominantly inherited moderate lifetime risk for cancers including breast and colorectal (Meijers-Heijboer et al. 2002; Xiang et al. 2011). The gene discussed is CHEK2; the disease is cancer.